Bruno Brochet

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Natural History of Multiple Sclerosis with Childhood Onset

Christel Renoux, Sandra Vukusic, Yann Mikaeloff et al. · New England Journal of Medicine · 2007 · 591 citations · Full text

Education, Neurology, Disability Management +16

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations

Life Sciences, Neurology, Neuroscience +17

Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

Darin T. Okuda, Orhun H. Kantarci, Matilde Inglese et al. · PLoS ONE · 2014 · 332 citations · Full text

Medicine, Neurology, Neuroscience +15

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Ayman Tourbah, Christine Lebrun‐Frénay, Gilles Edan et al. · Multiple Sclerosis Journal · 2016 · 287 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +10